Latest News
Chemed Corporation
- Chemed Corporation Estimates – LSX:A0CBF4
- Form 4 Chemed Corp: Joel L. Wherley (CEO - Vitas Healthcare) For: 20 October
- Will Earnings Beat Change Chemed (CHE) Stock Narrative
- UBS sets USD 650.00 target for Chemed stock
- 43,304 Shares in Chemed Corporation $CHE Purchased by Assenagon Asset Management S.A.
- Seven analysts set USD 554.60 target for Chemed stock
- UBS sets USD 650.00 target for Chemed stock, 26.11 percent above price
- Chemed (CHE): Buy, Sell, or Hold Post Q2 Earnings?
- Chemed To Report Third Quarter 2026 Earnings October 27, Related Conference Call To Be Held On October 28
- Chemed (CHE) Stock Analysis Report | Ratings, Financials & Performance
- Chemed (NYSE:CHE) Stock Forecast & Analyst Predictions
- UBS initiates Chemed stock coverage with buy rating on growth outlook
Headlines from the last 30 days, linking to the original publishers. See all market news →